New York Attorney General
NY-AG v. Quincy
Unknown
Quincy Bioscience Holding Company, Inc., Quincy Bioscience, LLC, Prevagen, Inc., Quincy Bioscience Manufacturing, LLC allegedly made fraudulent and deceptive statements about the supplement Prevagen. According to NY-AG, Quincy had not substantiated any of its claims about Prevagen with reliable scientific evidence, and some of Quincy’s claims about Prevagen may be materially misleading and all of them may have the tendency to deceive and constitute fraud under New York Executive Law Section 63(12)
Summary generated from official New York Attorney General press release
Source: New York Attorney General Press Release ↗Parties
Defendants / Respondents
- Quincy Bioscience Holding Company, Inc.
- Quincy Bioscience, LLC
- Prevagen, Inc.
- Quincy Bioscience Manufacturing, LLC
- Letitia James
- Federal Trade Commission
- Louis L. Stanton
Dates
Resolved
May 7, 2024
Case Details
Industry
Pharmaceutical
Penalty Type
Injunction